Literature DB >> 8049811

Effect of endogenous and inhaled nitric oxide on the ventilation-perfusion relationships in oleic-acid lung injury.

C Putensen1, J Räsänen, J B Downs.   

Abstract

Previous investigations have shown that the ventilation-perfusion (VA/Q) mismatch caused by acute lung injury can be alleviated either by inducing vasodilation in ventilated lung units with inhaled nitric oxide (NO) or by inhibiting the synthesis of endogenous NO, which opposes hypoxic pulmonary vasoconstriction. To determine the effects of a combination of these interventions, we evaluated cardiopulmonary function and VA/Q distributions in 10 dogs with oleic acid-induced lung injury. Each animal received, in random order, zero or 40 ppm of NO in inspiratory gas, with and without intravenous infusion of NG-monomethyl-L-arginine (L-NMMA) (5 mg/kg/h). The multiple inert-gas elimination technique was used to estimate VA/Q distributions. Systemic L-NMMA administration alone did not affect VA/Q inequality and gas exchange, but increased pulmonary and systemic vascular resistance. Inhaled NO improved gas exchange by redistributing blood flow from shunt units to lung units with a nearly ideal VA/Q ratio, without affecting pulmonary or systemic vascular resistance. Improved VA/Q matching and gas exchange was most pronounced when NO was inhaled in the presence of systemic L-NMMA. Inhalation of NO reversed the pulmonary but not the systemic vasoconstriction caused by L-NMMA. These results suggest that endogenous NO release is not limited to hypoxic lung regions in animals with oleic acid-induced lung injury. Inhaled NO reversed L-NMMA-induced pulmonary vasoconstriction and improved VA/Q matching by selectively dilating the pulmonary vasculature in ventilated lung units.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8049811     DOI: 10.1164/ajrccm.150.2.8049811

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  8 in total

Review 1.  Response to inhaled nitric oxide in premature and term neonates.

Authors:  T Hoehn; M F Krause
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  The effects of cardiac output and pulmonary arterial hypertension on volumetric capnography derived-variables during normoxia and hypoxia.

Authors:  Martina Mosing; Annette P N Kutter; Samuel Iff; Joanna Raszplewicz; Jacqueline Mauch; Stephan H Bohm; Gerardo Tusman
Journal:  J Clin Monit Comput       Date:  2014-06-08       Impact factor: 2.502

3.  Randomised trial of three doses of inhaled nitric oxide in acute respiratory distress syndrome.

Authors:  S F Tang; M C Sherwood; O I Miller
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

Review 4.  Gene Therapy for Acute Respiratory Distress Syndrome.

Authors:  Jing Liu; David A Dean
Journal:  Front Physiol       Date:  2022-01-17       Impact factor: 4.566

Review 5.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

6.  Pretreatment with N-nitro-L-arginine methyl ester improved oxygenation after inhalation of nitric oxide in newborn piglets with Escherichia coli pneumonia and sepsis.

Authors:  Yun Sil Chang; Saem Kang; Sun Young Ko; Won Soon Park
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

7.  Pathophysiological Approaches of Acute Respiratory Distress syndrome: Novel Bases for Study of Lung Injury.

Authors:  R L Castillo; R Carrasco Loza; C Romero-Dapueto
Journal:  Open Respir Med J       Date:  2015-06-26

Review 8.  Animal models of acute lung injury.

Authors:  Gustavo Matute-Bello; Charles W Frevert; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.